TRIER PHARM ApS: Financial statements 2013
CVR: 31611083
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
TRIER PHARM ApS (CVR 31611083) has filed annual accounts for 2013. In 2013, the company reported revenue of DKK 260,750 and a net result of DKK -21,476 compared with DKK 42,979 the year before. That is an increase of 47.4% compared with the year before. The profit margin was -8.2%. Equity in the 2013 report amounted to DKK 756,138. The solvency ratio was 70.2%.
- Revenue
- DKK 260,750
- Gross Profit
- DKK -17,146
- Profit/Loss
- DKK -21,476
- Equity
- DKK 756,138
- Total Assets
- DKK 1,077,194
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2013 | 261 t. | -17 t. | -21 t. | 756 t. | - |
| 2012 | 177 t. | 53 t. | 43 t. | 778 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
TRIER PHARM ApS has published its annual report for 2012. Revenue came to DKK 176,939, and the net result was DKK 42,979.
About TRIER PHARM ApS
TRIER PHARM ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2008. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Klaus Trier. The company is owned by KLAUS TRIER HOLDING ApS. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK -37,612 and a net result of DKK -67,143 compared with DKK -18,582 the year before. Equity in the 2025 report amounted to DKK -632,769.